EMERALD ADVISERS, LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 75 filers reported holding TRANSMEDICS GROUP INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$24,229,394
-33.8%
442,546
+1.5%
1.17%
-26.7%
Q2 2023$36,623,090
+12.3%
436,093
+1.3%
1.60%
+2.4%
Q1 2023$32,605,703
-6.1%
430,552
-23.5%
1.56%
-6.8%
Q4 2022$34,727,807
+68.1%
562,667
+13.7%
1.68%
+57.4%
Q3 2022$20,658,000
+65.2%
494,926
+24.5%
1.07%
+65.8%
Q2 2022$12,503,000
+65.2%
397,565
+41.5%
0.64%
+122.5%
Q1 2022$7,569,000
+61.4%
280,953
+14.8%
0.29%
+67.1%
Q4 2021$4,691,000
-44.0%
244,816
-3.4%
0.17%
-43.1%
Q3 2021$8,384,000
-15.9%
253,378
-15.7%
0.30%
-16.3%
Q2 2021$9,969,000
-60.3%
300,464
-50.3%
0.36%
-59.9%
Q1 2021$25,100,000
+87.5%
604,975
-10.1%
0.91%
+104.1%
Q4 2020$13,390,000
+49.2%
672,880
+3.3%
0.44%
+20.3%
Q3 2020$8,973,000
-25.2%
651,183
-2.7%
0.37%
-29.4%
Q2 2020$11,997,000
+119.2%
669,467
+47.8%
0.52%
+65.0%
Q1 2020$5,473,000
-36.2%
453,078
+0.3%
0.32%
-12.7%
Q4 2019$8,584,000
+73.3%
451,542
+116.6%
0.36%
+57.1%
Q3 2019$4,952,000
-19.2%
208,508
-1.4%
0.23%
-6.1%
Q2 2019$6,132,000211,5080.25%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2020
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders